The transaction values Grupo IMO in ¤50M. Upon deal completion, NAZCA will retain a majority shareholding in the company.
In a closing speech marking the second edition of the Masters and the opening ceremony of the third edition, Mr José Sanblás, chairman of Grupo IMO and Grupo IMO Foundation advocated for the application of the new technologies, such as real-time image-
Grupo IMO’s Psycho-Oncology unit ran a pilot study proving that 9 out of 10 breast cancer patients deem that enough emotional and instrumental support was provided by their relatives, whereas 8 out of 10 claim that they received enough emotional
As authorized member of the Excellent Private Health Care Program, Grupo IMO - Madrid's Institute of Oncology has been awarded both prizes for its continued business and healthcare excellence. Both prizes were awarded by Áliad, a leading expert in trai
Team of Robotic Radiation Therapy Surgery with Cyberknife.
Both institutions have entered into a joint cooperation agreement with teaching, research and assistance purposes in order to strengthen the fight against cancer.
Official opening of the International IORT Course organized by Grupo IMO Foundation
Robotic Radiation Therapy with Cyberknife shortens treatment times and avoids side effects such as urinary incontinence and sexual dysfunction.
Radiation therapy with TOMOTHERAPY is more efficient, less toxic and improves breast cancer patients’ quality of life.